drugset / Trial / NCT02079701

Effectiveness of the Pneumococcal Polysaccharide Vaccine in Military Recruits

NCT02079701 ↗

RandomizedParallel-groupTriple-blindTreatment

Summary

The primary objective is to determine the clinical benefit of employing the 23-valent pneumococcal vaccine among US military trainees. Secondary objectives include: * determining the etiology of clinical pneumonia among U.S. military trainees; * comparing the serotype distribution of S. pneumoniae (Sp) isolates recovered from vaccinated and nonvaccinated trainees diagnosed with pneumonia; and * comparing days lost from training due to pneumonia or acute respiratory disease for vaccinated and nonvaccinated subjects.

Timeline

Start
2000-10
Primary completion
2003-06
Completion
2007-06

Outcome

Missed primary endpoint

paper Cox's proportional hazard modeling revealed no evidence of a protective vaccine effect during recruit training (radiographically confirmed pneumonia). PMID 25579777 ↗

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject 23-valent pneumococcal vaccine Vaccine 0.5 ml Intramuscular

Indications